Table 2.
Comparison of clinical variables in patients with resected colon cancer on surveillance colonoscopy treated with flavonoids vs controls
| Flavonoid treatment (n = 14, %) | Controls (n = 15, %) | P value | |
| Males/females | 7/7 | 7/8 | > 0.9 |
| Age (yr) median (IQR) | 75.0 (77-82) | 81.0 (77-86) | 0.12 |
| BMI (kg/m²) median (IQR) | 26.2 (24.6-28.0) (n = 13) | 25.9 (24.5-27.5) (n = 10) | 0.57 |
| Smoker/non-smoker | 0/13 (0) | 1/12 (8) | > 0.9 |
| Alcohol habitual/no | 13/0 (100) | 7/5 (58) | 0.0151 |
| Black tea/no | 5/9 (36) | 8/5 (61) | 0.26 |
| Green tea/no | 5/8 (36) | 5/6 (45) | > 0.9 |
| Fruit intake < 3/≥ 3 d a week) | 2/11 (15) | 2/10 (17) | > 0.9 |
| Vegetable intake < 3/≥ 3 d a week) | 6/7 (46) | 8/4 (67) | 0.43 |
| Aspirin/no | 4/10 (28) | 7/7 | 0.44 |
| NSAID/no | 0/14 (0) | 1/13 (7) | > 0.9 |
| Colon vs rectum cancer | 13/1 (93) | 9/6 (60) | 0.080 |
| Low vs high tumor stage (I and II/III) | 9/5 (64) | 9/6 (60) | > 0.9 |
| Surveillance time by colonoscopy | |||
| Years: median (IQR) | 4.0 (3.25-5) | 3.0 (2-3) | 0.0221 |
IQR: Interquartile range (25%-75%).
1
Significantly different at P < 0.05.